LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Art Pappas joins a Venture Capital Panel at BioContactQuébec 2012 on October 3 in Quebec City.
News | 08. 14. 2012
Art Pappas joins a Venture Capital Panel at BioContactQuébec 2012 on October 3 in Quebec City.
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.